Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

Herantis Pharma has dosed the first patients in the final cohort of its phase 1b clinical trial assessing HER-096, a ...

First Biomarker Analysis from Phase 1b Study of GT-02287 in Parkinson's Disease Expected Mid-2025BETHESDA, Md., May 14, 2025 (GLOBE NEWSWIR ...

Neighborhoods near golf courses are often considered desirable locations, blending nature, leisure and nice views. However, a ...

People may be paying a hidden price for living close to a golf course. Recent research has found a link between golf courses ...

There is promising research that indicates cell death can be blocked, thus halting the progression of Parkinson’s Disease.

The pitch and hoarseness of a person's voice often changes if they have Parkinson's disease, suggesting there could be a ...

Michael J. Fox and wife Tracy Pollan had a night out on the town in NYC when they sat courtside at the Knicks-Celtics NBA ...

Press release First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson’s disease HER-096 is a first-in-class agent in development for the treatment of Parkinson’s ...

Bruce Walker knew something wasn’t right when he began experiencing dizziness when rising to stand. He also lacked a sense of ...

KEY HIGHLIGHTS First patient expected to start therapy by end of Q2-2025 in Phase 2a proof-of concept clinical trial for ...

A PDF of the poster presented at IAPRD 2025 30 th World Congress on Parkinson's Disease and Related Disorders is available on ...